The Source Blog
Recent Action in Pharmaceuticals
HF5469 – Minnesota
Introduced: 2024 Status:
Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to drug with lowest out-of-pocket cost to …
SB521 – Kansas
Introduced: 2024 Status:
AN ACT concerning insurance; relating to pharmacy benefit managers; imposing restrictions concerning the federal 340B drug pricing program; enacting the defense of affordable prescriptions act to prohibit certain discriminatory actions related to reimbursement of entities …
HB24-1438 – Colorado
Introduced: 2024 Status: Enacted
Concerning the implementation of certain affordable prescription drug programs, and, in connection therewith, making an appropriation.
HB 238 – Alabama
Introduced: 2024 Status:
This bill aims to further regulate the practice of pharmacy benefits managers (PBMs) in Alabama. PBMs are intermediaries between insurers and pharmacies that manage prescription drug benefits on behalf of health insurance providers. The bill …
SB 241 – Connecticut
Introduced: 2024 Status:
To require entities authorized to participate in the federal 340B Drug Pricing Program to report to the Health Systems Planning Unit of the Office of Health Strategy certain information regarding the program, including (1) aggregated …
SF 333 – Iowa
Introduced: 2024 Status: In Process
This bill aims to regulate pharmacy benefits managers (PBMs), pharmacies, and prescription drug benefits. It requires that any payments a covered person makes for a prescription drug must be applicable to any deductibles in the …
SF 554 – Iowa
Introduced: 2024 Status: In Process
This bill is designed to regulate the operations of Pharmacy Benefits Managers (PBMs) in the state of Iowa. It introduces a system of reverse auctions to determine which PBM will provide services for public sector …
Next | See all Legislation Records
Introduced: 2024 Status:
Pharmacy benefit managers and health carriers required to include lower-cost drugs in their formularies, and formulary structure and formulary tiering for each health plan required to give preference to drug with lowest out-of-pocket cost to …
SB521 – Kansas
Introduced: 2024 Status:
AN ACT concerning insurance; relating to pharmacy benefit managers; imposing restrictions concerning the federal 340B drug pricing program; enacting the defense of affordable prescriptions act to prohibit certain discriminatory actions related to reimbursement of entities …
HB24-1438 – Colorado
Introduced: 2024 Status: Enacted
Concerning the implementation of certain affordable prescription drug programs, and, in connection therewith, making an appropriation.
HB 238 – Alabama
Introduced: 2024 Status:
This bill aims to further regulate the practice of pharmacy benefits managers (PBMs) in Alabama. PBMs are intermediaries between insurers and pharmacies that manage prescription drug benefits on behalf of health insurance providers. The bill …
SB 241 – Connecticut
Introduced: 2024 Status:
To require entities authorized to participate in the federal 340B Drug Pricing Program to report to the Health Systems Planning Unit of the Office of Health Strategy certain information regarding the program, including (1) aggregated …
SF 333 – Iowa
Introduced: 2024 Status: In Process
This bill aims to regulate pharmacy benefits managers (PBMs), pharmacies, and prescription drug benefits. It requires that any payments a covered person makes for a prescription drug must be applicable to any deductibles in the …
SF 554 – Iowa
Introduced: 2024 Status: In Process
This bill is designed to regulate the operations of Pharmacy Benefits Managers (PBMs) in the state of Iowa. It introduces a system of reverse auctions to determine which PBM will provide services for public sector …
Next | See all Legislation Records
Merck & Co., Inc. v. Becerra, et al. – Federal
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the …
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase …
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are …
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans …
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass …
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing …
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act …
Next | See all Litigation Records
District Court: District of Columbia Status: Pending
A complaint filed by Merck, a multinational pharmaceutical company, alleges that the drug price negotiation process detailed in the Inflation Reduction Act (IRA) violates the …
FTC v. Amgen Inc. & Horizon Therapeutics Plc. – Federal
District Court: Northern District of Illinois, Eastern Division Status: Pending
The FTC filed a lawsuit requesting a temporary restraining order and preliminary injunction to block Amgen Inc. from acquiring Horizon Therapeutics. Amgen agreed to purchase …
PhRMA v. Stolfi – Oregon
District Court: District Court of Oregon Status: Decided
PhRMA is challenging Oregon’s drug price transparency laws HB 4005, 2018 (Disclosure Law) and HB 2658, 2019 (Advance Notification Law) alleging that the laws are …
Pharmaceutical Care Management Association (PCMA) v. Mulready – Oklahoma
District Court: District Court of Western District of Oklahoma Status: Decided
The 2019 Oklahoma law, Patient’s Right to Pharmacy Choice Act, targets PBM conflict of interest by prohibiting higher reimbursement rates for PBM-owned pharmacies and bans …
State of Ohio v. OptumRx – Ohio
District Court: Ohio Court of Common Pleas (Franklin County) Status: Pending
On March 15, 2019, Ohio’s attorney general Dave Yost sued OptumRx in Ohio state court, claiming that between 2015 and 2018, the PBM failed to pass …
Pharm. Care Mgmt. Ass’n v. Gerhart – Iowa
District Court: Southern District of Iowa Status: Decided
Trade association representing pharmacy benefits managers (PBM) brought action against State of Iowa, seeking declaration that statute that regulated how PBMs established generic drug pricing …
Pharm. Care Mgmt. Ass’n v. Tufte – North Dakota
District Court: District of North Dakota Status: Pending
Trade association representing pharmacy benefit managers (PBMs) brought action against North Dakota state officials in their official capacities, alleging that Employee Retirement Income Security Act …
Next | See all Litigation Records
News & Opinions
Articles & Reports
Health Affairs
August 29, 2024
Health Affairs August 13, 2024
Health Affairs August 5, 2024
JAMA Internal Medicine December 4, 2023
Health Affairs August 13, 2024
Health Affairs August 5, 2024
JAMA Internal Medicine December 4, 2023
Trends in Pharmaceuticals
2019 Pharmaceutical Legislation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2019 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Transparency
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Rate Setting
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Price Gouging
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Drug Importation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharmacy Gag Clause Regulation
Gag clause regulation includes laws that allow pharmacists to disclose costs to insured patients and those that prohibit pharmacists from collecting more in cost-sharing from the insured patient than the cash price. See The Source’s Spotlight on 2018 State Drug Legislation Part 3 and 2018 legislation chart for more information.
-
Key:
- Enacted
- Considered
- No Legislative Session
PBM Regulation
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session
Pharma Other
Click on highlighted states to see all legislative action to regulate pharmaceutical price and competition in the 2018 session.
-
Key:
- Enacted
- Considered
- No Legislative Session